000788.SZ
PKU HealthCare Corp., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.51
−2.13%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
13.9x
Market Cap
CNY 3.28B
MomentumView details →
1D Return
−2.13%
YTD Return
−9.66%
RSI (14)
47.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
13.9x
Market Cap
CNY 3.28B
RSI (14)
47.7
MomentumView details →
1D Return
−2.13%
YTD Return
−9.66%
Similar companies
Latest newsMore news →
Southwest Synthetic Pharmaceutical Group, a shareholder holding over 5% of Peking University Pharmaceutical, had 1% of the company's shares (5.96 million shares) forcibly sold by Zhongtai Securities via centralized bidding from August 5 to September 1, 2026, due to a margin trading dispute, reducing its stake to 20.22%.4d agoPeking University Founder Pharmaceutical Co., Ltd. proposed a cash dividend of 0.20 yuan per 10 shares (tax included) based on 596 million shares, with no bonus shares and no capital reserve conversion.13d agoPeking University Founder Pharmaceutical Co., Ltd. announced its first-half 2026 results: revenue of 447 million yuan, down 53.30% year-on-year; net profit attributable to shareholders of 55.6708 million yuan, down 44.49% year-on-year; non-recurring net profit of 43.3238 million yuan, down 55.87% year-on-year.13d ago